Document Detail


Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial.
MedLine Citation:
PMID:  9307534     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine whether nitric oxide donors can induce cervical ripening before surgical termination of pregnancy in the first trimester. DESIGN: Prospective, randomised controlled trial. SETTING: Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow. PARTICIPANTS: Forty-eight primigravid women undergoing surgical termination of pregnancy before 12 weeks of gestation. METHODS: The women were randomised to receive per vaginam before surgery either the nitric oxide donor isosorbide mononitrate, the nitric oxide donor glyceryl trinitrate, the prostaglandin analogue gemeprost, or no treatment. MAIN OUTCOME MEASURES: The cumulative force required to dilate the cervix to 8 mm was measured objectively and the cervical diameter before surgical dilatation was recorded. RESULTS: Following isosorbide mononitrate or gemeprost, a lower cumulative force was required to dilate the cervix to 8 mm and a higher cervical diameter before dilatation was recorded. Pretreatment with glyceryl trinitrate reduced the cumulative force required to dilate the cervix but had no effect on cervical diameter. CONCLUSIONS: Like the prostaglandin analogue gemeprost, the nitric oxide donors isosorbide mononitrate and glyceryl trinitrate can effect cervical ripening. Nitric oxide donors may provide an alternative to prostaglandins for cervical ripening before surgical procedures in the first trimester.
Authors:
A J Thomson; C B Lunan; A D Cameron; I T Cameron; I A Greer; J E Norman
Related Documents :
12570814 - Nitric oxide and its role during pregnancy: from ovulation to delivery.
1351004 - Sonographic assessment of the incompetent cervix in pregnancy.
17260334 - Dystonia gravidarum: a new case with a long follow-up.
16308894 - Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm deliv...
20091584 - Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women.
22014504 - Circulatory and renal consequences of pregnancy in diabetic nod mice.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  104     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1997 Sep 
Date Detail:
Created Date:  1997-10-23     Completed Date:  1997-10-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1054-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynaecology, University of Glasgow.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / therapeutic use*
Abortion, Induced / methods*
Administration, Intravaginal
Adult
Alprostadil / analogs & derivatives
Cervix Uteri / drug effects*
Female
Humans
Isosorbide Dinitrate / analogs & derivatives,  therapeutic use
Nitric Oxide / therapeutic use*
Pregnancy
Pregnancy Trimester, First
Prospective Studies
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 10102-43-9/Nitric Oxide; 16051-77-7/isosorbide-5-mononitrate; 64318-79-2/gemeprost; 745-65-3/Alprostadil; 87-33-2/Isosorbide Dinitrate
Comments/Corrections
Comment In:
Br J Obstet Gynaecol. 1997 Dec;104(12):1422   [PMID:  9422031 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sex ratios: are there natural variations within the human population?
Next Document:  Extra-amniotic saline infusion for induction of labour in antepartum fetal death: a cost effective m...